• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chinese expert consensus on the application of immune checkpoint inhibitors in liver transplantation for hepatocellular carcinoma.

作者信息

Wang Zhengxin, Yang Jiayin, Li Guangming

机构信息

Liver Transplantation Center, General Surgery Department, Huashan Hospital Affiliated to Fudan University, Organ Transplantation Institute of Fudan University, Shanghai 200040, China.

Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610044, China.

出版信息

Chin Med J (Engl). 2024 Sep 20;137(18):2143-2145. doi: 10.1097/CM9.0000000000003237. Epub 2024 Aug 15.

DOI:10.1097/CM9.0000000000003237
PMID:39148191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11407808/
Abstract
摘要

相似文献

1
Chinese expert consensus on the application of immune checkpoint inhibitors in liver transplantation for hepatocellular carcinoma.免疫检查点抑制剂在肝细胞癌肝移植中应用的中国专家共识
Chin Med J (Engl). 2024 Sep 20;137(18):2143-2145. doi: 10.1097/CM9.0000000000003237. Epub 2024 Aug 15.
2
[Chinese multidisciplinary expert consensus on combined immunotherapy based on immune checkpoint inhibitors for hepatocellular carcinoma(2021 version)].《中国肝细胞癌免疫检查点抑制剂联合免疫治疗多学科专家共识（2021年版）》
Zhonghua Gan Zang Bing Za Zhi. 2021 Jul 20;29(7):636-647. doi: 10.3760/cma.j.cn501113-20210604-00261.
3
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).基于免疫检查点抑制剂与抗血管生成靶向药物联合的晚期肝细胞癌转化治疗后序贯手术中国专家共识（2024年版）
Biosci Trends. 2025 Jan 14;18(6):505-524. doi: 10.5582/bst.2024.01394. Epub 2024 Dec 25.
4
[Expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma(2024 edition)].基于免疫检查点抑制剂与抗血管生成靶向药物联合的晚期肝细胞癌转化治疗后序贯手术专家共识（2024年版）
Zhonghua Wai Ke Za Zhi. 2024 Nov 1;62(11):984-995. doi: 10.3760/cma.j.cn112139-20240814-00245.
5
[Chinese multidisciplinary expert consensus on combined immunotherapy for hepatocellular carcinoma(2023 version)].《中国肝细胞癌联合免疫治疗多学科专家共识（2023年版）》
Zhonghua Gan Zang Bing Za Zhi. 2023 Jan 20;31(1):16-34. doi: 10.3760/cma.j.cn501113-20221215-00602.
6
[Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma ( version 2024)].《肝细胞癌靶向药物和免疫检查点抑制剂相关肝损伤管理的专家共识（2024版）》
Zhonghua Gan Zang Bing Za Zhi. 2024 Dec 20;32(12):1086-1097. doi: 10.3760/cma.j.cn501113-20241014-00539.
7
Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition).《中国肝细胞癌免疫检查点抑制剂联合治疗多学科专家共识（2023年版）》
Liver Cancer. 2024 Jan 16;13(4):355-375. doi: 10.1159/000535496. eCollection 2024 Aug.
8
[Chinese expert consensus on neoadjuvant therapy for hepatocellular carcinoma (2023 edition)].《肝细胞癌新辅助治疗中国专家共识（2023年版）》
Zhonghua Wai Ke Za Zhi. 2023 Dec 1;61(12):1035-1045. doi: 10.3760/cma.j.cn112139-20230914-00121.
9
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition).《中国肝细胞癌免疫治疗专家共识（2021年版）》
Liver Cancer. 2022 Jul 20;11(6):511-526. doi: 10.1159/000526038. eCollection 2022 Dec.
10
[Immunotherapy clinical application and research prospects for liver cancer].[肝癌的免疫治疗临床应用及研究前景]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jul 20;29(7):615-617. doi: 10.3760/cma.j.cn501113-20210622-00297.

引用本文的文献

1
Immune checkpoint inhibitors use in liver transplantation for hepatocellular carcinoma: a global cohort study.免疫检查点抑制剂在肝细胞癌肝移植中的应用：一项全球队列研究。
BMC Med. 2025 Sep 2;23(1):515. doi: 10.1186/s12916-025-04352-z.

本文引用的文献

1
Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition).中国肝细胞癌肝移植临床实践指南（2021年版）
Chin Med J (Engl). 2022 Dec 20;135(24):2911-2913. doi: 10.1097/CM9.0000000000002515.